Business Context and Reporting Period
Company: SS&C Technologies Holdings Inc. (SSNC)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: SS&C is a leading provider of software-enabled services and solutions for the financial services and healthcare industries. Key offerings include fund administration (GlobeOp), transfer agency (GIDS), virtual data rooms (Intralinks), intelligent automation (Blue Prism), and healthcare claims processing (SS&C Health). The company operates globally with over 28,000 employees and 23,000 clients.
Key Financial Metrics (Fiscal Year 2025)
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Total Revenues | $6,272.2 million | $5,882.0 million | +6.6% |
| Software-Enabled Services Revenue | $5,211.1 million | $4,840.3 million | +7.7% |
| License, Maintenance & Related Revenue | $1,061.1 million | $1,041.7 million | +1.9% |
| Gross Profit | $3,021.6 million | $2,863.6 million | +5.5% |
| Gross Margin | 48.2% | 48.7% | -50 bps |
| Operating Income | $1,436.7 million | $1,343.5 million | +6.9% |
| Net Income (Attributable to SS&C) | $796.9 million | $760.5 million | +4.8% |
| Diluted EPS | $3.15 | $3.00 | +5.0% |
| Operating Cash Flow | $1,744.8 million | $1,388.6 million | +25.6% |
| Total Debt | $7,466.9 million | $7,009.6 million | +6.5% |
| Cash & Equivalents (Total) | $3,573.8 million | $3,370.5 million | +6.0% |
Note: Total cash includes $3,107.2 million held on behalf of clients.
Material Changes vs. Prior Period
- Revenue Growth: Driven by a $281.2 million increase in organic revenue (strength in GlobeOp, GIDS, and Wealth/Investment Technologies) and $77.5 million from acquisitions. Foreign currency translation provided a favorable impact of $31.5 million.
- Acquisitions: Significant M&A activity included the acquisition of Calastone Limited (October 2025, ~$1.03 billion) to expand global funds networks, FPS Trust Company (February 2025), and Curo Fund Services (November 2025). In 2024, the company acquired Battea-Class Action Services (~$671 million).
- Cost Structure: Cost of revenues increased 7.7% due to organic growth investments and acquisition integration. Operating expenses rose 4.3% primarily due to resource needs for organic growth and acquisition-related costs.
- Debt Profile: Total indebtedness increased to $7.47 billion. In October 2025, the company borrowed an additional $1.05 billion in Term B-8 loans to finance the Calastone acquisition. Interest expense decreased to $434.7 million (from $463.0 million in 2024) due to lower average interest rates.
- Tax Rate: The effective tax rate was 18.1% in 2025, compared to 14.8% in 2024. The increase was driven by the release of uncertain tax positions and changes in the composition of income between foreign and domestic jurisdictions.
Guidance, Outlook, and Risks
Management Commentary & Strategy:
- AI & Automation: Management emphasizes the integration of Artificial Intelligence (AI) and Robotic Process Automation (RPA) via Blue Prism to drive efficiency and offer "agentic" solutions to clients. The company utilizes its own automation technology internally ("Customer Zero") to validate solutions.
- Healthcare Growth: SS&C Health continues to expand, processing over 600 million claims in 2025. The strategy focuses on cloud-native, modular platforms to help payers reduce costs and improve member engagement.
- Capital Allocation: The company remains committed to a disciplined acquisition strategy, share repurchases, and dividends. In 2025, the company repurchased $1.036 billion of common stock and paid $253.8 million in dividends.
Risks & Contingencies:
- Indebtedness: Substantial debt levels ($7.47 billion) require significant cash flow for service. The company is subject to restrictive covenants, including a maximum consolidated net secured leverage ratio (currently 1.70x vs. 6.25x limit).
- Acquisition Integration: Risks associated with integrating recent large acquisitions (Calastone, Battea) and realizing anticipated synergies.
- Cybersecurity: As a custodian of sensitive financial and healthcare data, the company faces significant risks from cyber-attacks, data breaches, and IT system failures.
- Regulatory Environment: Evolving regulations in financial services (e.g., AIFMD, Dodd-Frank) and healthcare (e.g., HIPAA, state privacy laws) increase compliance costs and operational complexity.
- Geopolitical & Economic: Exposure to international markets (33% of revenue) creates risks related to currency fluctuations, geopolitical tensions, and economic downturns affecting client spending.
Investor Verification Checklist
- Acquisition Integration: Verify the progress of integrating Calastone and Battea, specifically regarding revenue retention and cost synergies.
- Debt Covenants: Monitor the consolidated net secured leverage ratio to ensure continued compliance with the 6.25x threshold, especially given the increased debt load from recent acquisitions.
- AI Monetization: Assess the actual revenue contribution from new AI and agentic automation solutions versus the investment costs in R&D ($507.5 million in 2025).
- Client Concentration: Confirm that no single client exceeds 5% of revenue, maintaining the diversified client base profile.
- Healthcare Segment Performance: Review the growth trajectory and margin profile of SS&C Health, particularly regarding claims processing volumes and contract renewals.
- Stock Repurchase Program: Track the remaining authorization under the $1.5 billion repurchase program authorized in May 2025 (approx. $919 million remaining as of Dec 31, 2025).